HealthCareMagic is now Ask A Doctor - 24x7 | https://www.askadoctor24x7.com

Get your health question answered instantly from our pool of 18000+ doctors from over 80 specialties
159 Doctors Online

By proceeding, I accept the Terms and Conditions

Dr. Andrew Rynne
MD
Dr. Andrew Rynne

Family Physician

Exp 50 years

HCM Blog Instant Access to Doctors
HCM BlogQuestions Answered
HCM Blog Satisfaction

What Would Be The Advantage Of Sorafenib Over Thereasphere For Liver Cancer?

My husband has primary liver cancer. He has had two ThereaSphere treatments which have shrunk the tumour from 10.4 by 9.1 to 6.7 by 7.2. They are considering Sorafenib as a possible treatment as opposed to continuing with ThereaSphere. His liver function is good. What would be the advantages of Sorafenib over continuing with ThereaSphere?
Wed, 14 May 2014
Report Abuse
Oncologist 's  Response
Sorafenib is a type of targeted therapy known as a kinase inhibitor.

Kinases are proteins on or near the surface of a cell that transmit important signals to the cell’s control center. Sorafenib blocks several kinase proteins that either prompt tumor cells to grow or help form new blood vessels (angiogenesis) to feed the tumor. By blocking these proteins, sorafenib can help stop the growth of cancer cells.
Sorafenib in liver cancer showed improvement in median overall survival of 44% Both median survival and time to progression showed 3-month improvements. There was no difference in quality of life measures, possibly attributable to toxicity of sorafenib or symptoms related to underlying progression of liver disease.
Regards
Dr De
I find this answer helpful

Note: For further queries related to kidney problems Click here.
Disclaimer: These answers are for your information only and not intended to replace your relationship with your treating physician.
This is a short, free answer. For a more detailed, immediate answer, try our premium service [Sample answer]
Share on
 

Related questions you may be interested in


Recent questions on Sorafenib


Loading Online Doctors....
What Would Be The Advantage Of Sorafenib Over Thereasphere For Liver Cancer?

Sorafenib is a type of targeted therapy known as a kinase inhibitor. Kinases are proteins on or near the surface of a cell that transmit important signals to the cell’s control center. Sorafenib blocks several kinase proteins that either prompt tumor cells to grow or help form new blood vessels (angiogenesis) to feed the tumor. By blocking these proteins, sorafenib can help stop the growth of cancer cells. Sorafenib in liver cancer showed improvement in median overall survival of 44% Both median survival and time to progression showed 3-month improvements. There was no difference in quality of life measures, possibly attributable to toxicity of sorafenib or symptoms related to underlying progression of liver disease. Regards Dr De